beta
/Compounds For Targeted Protein Degradation
Abstract

This disclosure provides a compound of formula (III): or a pharmaceutically acceptable salt, solvate or derivative thereof, wherein the substituents are as defined herein. The disclosure also provides pharmaceutical compositions comprising said compounds and the use of said compounds in the treatment of diseases, e.g. cancer.

Full Text

What is claimed is:

This disclosure provides a compound of formula (III): or a pharmaceutically acceptable salt, solvate or derivative thereof, wherein the substituents are as defined herein. The disclosure also provides pharmaceutical compositions comprising said compounds and the use of said compounds in the treatment of diseases, e.g. cancer.
Timeline
Filed
02/23/2026
Published
06/25/2026
Granted
Not Available
IPC Codes(5)
C07D 471/04:Ortho-condensed systems
A61K 31/499:Spiro-condensed pyrazines or piperazines
A61P 35/00:Antineoplastic agents